Is your enterprise data optimized for precision medicine? Break down siloes to achieve breakthrough outcomes.
Precision medicine is poised to reshape the way diseases are diagnosed, treated, and managed. Realizing the potential of precision medicine requires vast quantities of data – along with the ability to connect and interpret it in pursuit of highly personalized and targeted therapies.
Even so, many biopharma and diagnostics companies, laboratories, and healthcare providers are still challenged to manage data within their own enterprises. Within your organization, you may be dealing with siloed data that’s hindering your ability to identify and pursue opportunities related to precision medicine.
With the precision medicine landscape changing rapidly – and innovative technologies like generative AI gaining steam – organizations must adapt at pace. You need the ability to harmonize data from myriad sources within and outside your organization. You need the ability to transform all that data into insights you can act on. In other words, you need an end-to-end, enterprise approach to data and evidence management.
Position your organization for success in precision medicine. It’s better for patients, better for science, and better for growth.
Our thinking: A new era of precision medicine
A new era of precision medicine: The unprecedented impact of generative AI across the precision medicine landscape
Artificial intelligence and its expanding role across the biopharma landscape
AI and its expanding role across the biopharma landscape
The KPMG Precision Medicine practice is a leader in innovation across all therapeutic areas, in markets around the world.
Life Sciences in a Time of Stress
Optimizing enterprise data is key to precision medicine. It also helps address other industry challenges tied to cost and complexity. Here's how.
Precision medicine demands precision data to improve patient outcomes. AI can transform your enterprise into an engine for innovation and growth.
Stay in touch by signing up for the Healthcare & Life Sciences Institute.
Watch our global and US HCLS Deal Advisory and Strategy leader Kristin Pothier at the 2023 JP Morgan Healthcare Conference as she leads a panel discussion on the challenges and opportunities in the global precision medicine field.Learn more
Additional life science resources
Explore how KPMG helps life science and healthcare leaders build strategies, explore deals and design operating models for the new normal.
Popular category topics
The Dawn of Precision Medicine in Neurodegenerative Diseases
We are on the precipice of Precision Medicine in neurodegenerative diseases (NDDs)
Better patient experiences drive health access and equity
Seamless journeys drive better health outcomes and higher operational performance
Spatial omics – microenvironments in full resolution
KPMG perspective on this innovative technology
KPMG life sciences technology insights report
KPMG reports on the state of life sciences industry digital transformation, automation, artificial intelligence, and machine learning
Our Healthcare and Life Sciences Capabilities
We can help you anticipate and prepare for today’s Healthcare challenges and tomorrow’s possibilities.